Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
02-04

DJ Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. $(EW)$ slipped 1.48% to $71.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.76% to 5,994.57 and Dow Jones Industrial Average falling 0.28% to 44,421.91.

This was the stock's second consecutive day of losses.

Edwards Lifesciences Corp. closed 25.74% below its 52-week high of $96.12, which the company achieved on March 28th.

The stock underperformed when compared to some of its competitors Monday, as Abbott Laboratories $(ABT)$ rose 0.41% to $128.45, Medtronic PLC $(MDT)$ fell 0.32% to $90.53, and Stryker Corp. $(SYK)$ fell 0.04% to $391.14.

Trading volume (3.4 M) remained 1.5 million below its 50-day average volume of 4.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 03, 2025 16:52 ET (21:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10